Oncopeptides (STO: ONCO)

Last close As at 11/09/2025

SEK5.02

−0.46 (−8.39%)

Market capitalisation

SEK1,297m

Oncopeptides is a Swedish biotech company developing peptide-drug conjugates for the treatment of hematological cancers, with a focus on relapsed or refractory multiple myeloma.

Latest Insights

Healthcare | Non client QV

Oncopeptides — Targeted oncology with commercial momentum

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Sofia Heigis

    CEO

  • Henrik Bergentoft

    CFO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free